Explore › Outcome › Onset of
Outcome

Onset of

Also known as: Onset Onset (attribute) Onset of Onset of (contextual qualifier) Onset of (contextual qualifier) (qualifier value) Onset of ADHD (attention deficit/hyperactivity disorder) Onset of behavior problems (conduct problems, externalizing behaviors, aggression, anger management issues) Onset of depressed mood (depression, bipolar disorder) With onset With onset (qualifier value) With onset -RETIRED-
18 findings 1 paper 6 related entities View in graph →

Related entities

interventions
Corticosteroid use3 Mobility device3
conditions
dystrophinopathy6
populations
Children4 Males2
studys
PMC44979296

Findings (50)

None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
decline

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Size: HR=3.53 CI: 95%CI=2.13,5.85
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →
None
adverse

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Size: HR=2.35 CI: 95%CI=1.75,3.16
PMC4497929
Finding details → · Paper → · Graph →

Papers (1)